Cargando…
Crizotinib Shows Antibacterial Activity against Gram-Positive Bacteria by Reducing ATP Production and Targeting the CTP Synthase PyrG
Infections caused by drug-resistant bacteria are a serious threat to public health worldwide, and the discovery of novel antibacterial compounds is urgently needed. Here, we screened an FDA-approved small-molecule library and found that crizotinib possesses good antimicrobial efficacy against Gram-p...
Autores principales: | Zheng, Yun-Dan, Zhong, Tairan, Wu, Haiming, Li, Nan, Fang, Zuye, Cao, Linlin, Yin, Xing-Feng, He, Qing-Yu, Ge, Ruiguang, Sun, Xuesong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9241945/ https://www.ncbi.nlm.nih.gov/pubmed/35674439 http://dx.doi.org/10.1128/spectrum.00884-22 |
Ejemplares similares
-
Thiophenecarboxamide Derivatives Activated by EthA Kill Mycobacterium tuberculosis by Inhibiting the CTP Synthetase PyrG
por: Mori, Giorgia, et al.
Publicado: (2015) -
Structural basis of reiterative transcription from the pyrG and pyrBI promoters by bacterial RNA polymerase
por: Shin, Yeonoh, et al.
Publicado: (2020) -
A new vector for efficient gene targeting to the pyrG locus in Aspergillus niger
por: Arentshorst, Mark, et al.
Publicado: (2015) -
A multitarget approach to drug discovery inhibiting Mycobacterium tuberculosis PyrG and PanK
por: Chiarelli, Laurent R., et al.
Publicado: (2018) -
Molecular characterization of the niaD and pyrG genes from Penicillium camemberti, and their use as transformation markers
por: Navarrete, Katherinne, et al.
Publicado: (2009)